Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its executive team are scheduled to participate in the upcoming investor conference, detailed below. Participants will be Sonia Quaratino, Executive Vice President, Chief Medical Officer, Yannis Morel, Executive Vice President, Chief Operating Officer and Arvind Sood, Executive Vice President, President of US Operations.
- 2nd Annual H.C. Wainwright Cell Therapy Virtual Conference
Event Date: March 26, 2024 | virtual event
| Press Release in English | 123.28 KB |
| Communiqué de presse en français | 97.92 KB |